Opioid Receptors and Ligands: Targets for Cancer Imaging and TherapyJohn R. Lever1,2,3*
- *Corresponding Author:
- John R. Lever, Ph.D
Department of Radiology
University of Missouri – Columbia, M292 Medical Sciences Building
One Hospital Drive, Columbia, Missouri 65212 USA
Tel: +1-573-814-6000 ext. 53686
E-mail: [email protected]
Received date: November 16, 2012; Accepted date: November 23, 2012; Published date: November 26, 2012
Citation: Lever JR (2012) Opioid Receptors and Ligands: Targets for Cancer Imaging and Therapy. Med chem 2:142-147. doi:10.4172/2161-0444.1000131
Copyright: © 2012 Lever JR. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The roles played by classical and non-classical opioid receptors and their ligands in cancer are reviewed, starting with palliation of pain as the traditional linkage, then summarizing current research topics and clinical trials in cancer imaging and therapy, and concluding with a perspective on future directions for the field.